Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa

Journal of the International Association of Physicians in AIDS Care

Volumn 9, Issue 2, 2010, Pages 109-112

  Pérez, Ernesto Hernández ^a   Dawood, Haiima ^a,b  

^a GREY'S HOSPITAL   (South Africa)

^b NONE   (South Africa)

Author keywords

Highly active antiretroviral therapy; Hyperlactatemia; Lactic acidosis

Indexed keywords

EFAVIRENZ; LACTIC ACID; LAMIVUDINE; NEVIRAPINE; STAVUDINE;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; BODY MASS; CLINICAL FEATURE; EVENING DOSAGE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; INCIDENCE; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; SOUTH AFRICA; TERTIARY HEALTH CARE; WEIGHT REDUCTION;

ACIDOSIS, LACTIC; ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LACTATES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; STAVUDINE; YOUNG ADULT;

EID: 77953681097     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109710361536     Document Type: Article

References (15)

1. Ogedegbe AEO, Thomas DL, Diehl AM. Hyperlactatemia syndromes associated with HIV therapy. Lancet Infect Dis. 2003;3(6):329-337.
2. Gerard Y, Maulin L, Yazdanpanah Y, et al. Symptomatic hyperlactatemia: an emerging complication of antiretroviral therapy. AIDS. 2000;14(17):2723-2730.
3. Grimwood A, ed. National Antiretroviral Therapy Guidelines. Pretoria: Department of Health; 2004. http://www.hst.org.za/publications/624. Accessed February 03, 2008.
4. John M, Moore CB, James IR, et al. Chronic hyperlactatemia in HIV infected patients taking antiretroviral therapy. AIDS. 2001; 15(6):717-723.
5. Boubaker K, Flepp M, Sudre P, et al. Hyperlactatemia and antiretroviral therapy: the Swiss HIV cohort Study. Clin Infect Dis. 2001;33(11):1931-1937.
6. Moyle GJ, Datta D, Mandalia S, Morlese J, Asboe D, Gazzard BG. Hyperlactatemia and lactic acidosis during antiretro-viral therapy: relevance, reproducibility and possible risk factors. AIDS. 2002;16(10):1341-1349.
7. Moyle G. Hyperlactatemia and lactic acidosis. Should routine screening be considered? AIDS Read. 2002;12(8): 344-348.
8. Brinkman K. Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors. Clin Infect Dis. 2000; 31(1):167-169.
9. Brinkman K. Management of hyperlactatemia: no need for routine lactate measurements. AIDS. 2001;15(6):795-797.
10. Geddes R, Knight S, Moosa MY, Reddi A, Uebel K, Sunpath H. A high incidence of nucleoside reverse transcrip-tase inhibitor (NRTI)-induced lactic acidosis in HIV infected patients in a South African context. S Afr Med J. 2006;96(8): 722-724.
11. Wester CW, Okezie OA, Marlink Richard G, et al. Higher than expected rates of lactic acidosis among highly active antiretro-viral therapy-treated women in Botswana. J Acquir Immune Defic Syndr. 2007;46(3):318-322.
12. Bolhaar MG, Karstaedt AS. A High incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Clin Infect Dis. 2007;45(2):254-260.
13. Hernandez Perez E, Dawood H, Chetty U, Esterhuizen TM, Bizaree M. Validation of the Accutrend lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting. Int J Infect Dis. 2008;12(5):553-556.
14. Arenas-Pinto A. Risk factors for lactic acidosis and severe hyperlactatemia in HIV-1 infected adults exposed to antiretroviral therapy. Lactic Acidosis International Study Group. AIDS. 2007;21(18):2455-2464.
15. Fabian J, Venter DF, Mkhabela L, Levin JB, Baker L, Naicker S. Symptomatic hyperlactatemia in adults on antiretroviral therapy: a single center experience. South African Medical Journal. 2008; 98(10):795-800.